Product Details

Senvelgo 15 mg/ml Oral Solution for Cats

• MA holder: Boehringer Ingelheim Vetmedica GmbH
• VM number: EU/2/23/305/001
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Authorised from: 25/04/2024
• Authorisation route: Centralised
• Active substances:
  • Velagliflozin
• Target species:
  • Cats
• Distribution category: POM-V